| Cao, Jiang |
BRUIN CLL-321, NCT04666038: Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) |
|
|
| Active, not recruiting | 3 | 250 | Europe, Canada, Japan, US, RoW | LOXO-305, Pirtobrutinib, Idelalisib, Zydelig, Bendamustine, Treanda, Treakisym, Ribomustin, Levact, Rituximab, Rituxan, MabThera, Truxima | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 08/23 | 05/27 | | |
| Recruiting | 2 | 30 | RoW | individualized ATG dosing strategy | Chinese PLA General Hospital | Cytomegalovirus Infections, Infection Reactivation, Stem Cell Transplant Complications | 08/24 | 06/25 | | |
NCT04582604: Ruxolitinib and Decitabine for High Risk Hematological Malignancies |
|
|
| Recruiting | 1/2 | 60 | RoW | modified By/Cy conditioning regimen intensified by Ruxolitinib and Decitabine, Ruxolitinib and Decitabine | Chinese PLA General Hospital | Peripheral Blood Stem Cell Transplantation | 09/23 | 09/25 | | |
NCT05075681: Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma |
|
|
| Recruiting | 1/2 | 50 | RoW | Modified By/Cy conditioning regimen intensified by Ruxolitinib and Chidamide, Ruxolitinib and Chidamide | Chinese PLA General Hospital | Peripheral Blood Stem Cell Transplantation | 06/24 | 06/25 | | |
NCT04814004: Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors |
|
|
| Recruiting | 1 | 20 | RoW | hCD19.IL15.CAR-iNKT | Kai Lin Xu; Jun Nian Zheng, North Jiangsu People's Hospital, The First People's Hospital of Changzhou, Nantong University, First Affiliated Hospital of Zhejiang University, Affiliated Hospital of Jiangsu University, Huai 'an First People's Hospital | Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia | 04/23 | 04/24 | | |
NCT06593626: A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection |
|
|
| Recruiting | 1 | 28 | RoW | [18F]Florbetazine | HTA Co., Ltd. | MCI, AD | 09/24 | 09/24 | | |
NCT05907603: Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) |
|
|
| Recruiting | 1 | 18 | RoW | RD13-02 cell infusion | Kai Lin Xu，MD, Nanjing Bioheng Biotech Co., Ltd. | Neoplasms, Hematologic Neoplasms, Hematologic Diseases | 03/24 | 03/25 | | |
| Zheng, Junnian |
| Recruiting | 1/2 | 15 | RoW | fhB7H3.CAR-Ts | The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, IIT MediTech (Jiangsu) Co. Ltd | Ovarian Cancer | 08/23 | 08/26 | | |
NCT04814004: Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors |
|
|
| Recruiting | 1 | 20 | RoW | hCD19.IL15.CAR-iNKT | Kai Lin Xu; Jun Nian Zheng, North Jiangsu People's Hospital, The First People's Hospital of Changzhou, Nantong University, First Affiliated Hospital of Zhejiang University, Affiliated Hospital of Jiangsu University, Huai 'an First People's Hospital | Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia | 04/23 | 04/24 | | |
NCT06632964: A Clinical Trial Aimed At Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer |
|
|
| Recruiting | 1 | 16 | RoW | Recombinant oncolytic adenovirus injection solution of VT-101 | The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University | Non-muscle Invasive Bladder Cancer | 09/25 | 10/25 | | |
NCT04969354: Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell Carcinoma |
|
|
| Recruiting | 1 | 20 | RoW | CAR-T cell immunotherapy | The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University | Immunotherapy | 09/25 | 09/26 | | |
| Recruiting | 1 | 20 | RoW | CAR-T cell immunotherapy | The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University | Immunotherapy | 11/25 | 11/26 | | |
